Congress 118 - HR 4531 - Support for Patients and Communities Reauthorization Act

Sponsor

Cosponsors

Topics

Administrative law and regulatory procedures Cardiovascular and respiratory health Child safety and welfare Computers and information technology Congressional oversight Department of Health and Human Services Digestive and metabolic diseases Drug safety, medical device, and laboratory regulation Drug trafficking and controlled substances Drug, alcohol, tobacco use Employment and training programs Family services First responders and emergency personnel Government information and archives Government studies and investigations Health Health care coverage and access Health information and medical records Health personnel Health promotion and preventive care HIV/AIDS Labor market Medicaid Mental health Prescription drugs Smuggling and trafficking State and local finance State and local government operations Student aid and college costs Transportation costs Unemployment Veterinary medicine and animal diseases Women's health

Full Text

View Full Bill Text

Votes

Summary

Support for Patients and Communities Reauthorization Act

This bill reauthorizes through FY2028 and modifies various grants, programs, and activities that address substance use and misuse.

This includes reauthorizing (1) data collection, education, and surveillance activities; (2) grants and other support for substance use disorder prevention, treatment, and recovery; (3) student loan repayment and other programs for the substance use disorder workforce; and (4) programs for addressing trauma, particularly for children, youth, and their families. Generally, the modifications expand programs.

Additionally, the bill modifies provisions related to the scheduling of controlled substances, including by incorporating illicit xylazine (a compound used in veterinary medicine as a nonopioid tranquilizer) into schedule III of the Controlled Substances Act.

Further, the bill makes permanent a requirement that Medicaid programs cover medication-assisted treatment for individuals with substance use disorders.

Actions

Dec 13, 2023

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Dec 12, 2023

Motion to reconsider laid on the table Agreed to without objection.
Dec 12, 2023

On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 386 - 37 (Roll no. 715). (text: 12/11/2023 CR H6790-6794)
Dec 12, 2023

Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 386 - 37 (Roll no. 715). (text: 12/11/2023 CR H6790-6794)
Dec 12, 2023

Considered as unfinished business. (consideration: CR H6836)
Dec 11, 2023

At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Dec 11, 2023

DEBATE - The House proceeded with forty minutes of debate on H.R. 4531.
Dec 11, 2023

Considered under suspension of the rules. (consideration: CR H6789-6797)
Dec 11, 2023

Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
Sep 28, 2023

Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 29 - 3.
Sep 28, 2023

Committee Consideration and Mark-up Session Held
Jul 19, 2023

Ordered to be Reported (Amended) by the Yeas and Nays: 49 - 0.
Jul 19, 2023

Committee Consideration and Mark-up Session Held.
Jul 11, 2023

Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 11, 2023

Introduced in House

Amendments

Related Bills